Mast cells express the high-affinity receptor for IgE (FceRI) on their surface and are activated to secrete a variety of potently biologically active mediators in response to challenge with multivalent antigens. 1, 2) The release of such mediators from mast cells represents a critical component of many clinically important allergic reactions, various chronic inflammatory diseases, and innate immunity. 3, 4) The growth and development of mast cells are regulated by stem cell factor.
Mast cells express the high-affinity receptor for IgE (FceRI) on their surface and are activated to secrete a variety of potently biologically active mediators in response to challenge with multivalent antigens. 1, 2) The release of such mediators from mast cells represents a critical component of many clinically important allergic reactions, various chronic inflammatory diseases, and innate immunity. 3, 4) The growth and development of mast cells are regulated by stem cell factor. 1, 2) Mast cells in different anatomic microenvironments show variation in multiple aspects of their phenotypes and their sensitivity to various agents that can influence their functions. 1, 2) Rodent mast cells are subdivided into connective tissue mast cells (CTMCs) and mucosal mast cells (MMCs), and CTMCs exhibit several remarkable features that are shared neither with MMCs nor interleukin-3-dependent, immature, mouse bone marrow-derived mast cells (BMMCs). 1, 2) BMMC can be differentiated into CTMC-like cells in vitro after coculture with fibroblasts in the presence of adequate mast cell-poietic cytokines. [5] [6] [7] [8] To define comprehensively the profiles of expressed genes in immature and mature mast cells, we previously performed cDNA subtraction between BMMCs before and after coculture with fibroblasts to survey a panel of genes which is upregulated during the mast cell maturation process. 9, 10) Amongst a number of inducible genes identified so far, we found the N-myc downregulated gene (NDRG) 1 to be the most frequently induced gene during this in vitro mast cell maturation. 9) Moreover, overexpression of NDRG1 in the mast cell line RBL-2H3 results in an augmented exocytotic response, suggesting that NDRG1 allows mast cells to be differentiated into a phenotype that is more susceptible to various secretagogues.
NDRG1 is a member of the emerging NDRG family which also contains NDRG2, -3 and -4. 11, 12) The NDRG1 gene is mapped to human chromosome 8q24.2 and encodes a 43-kDa cytosolic protein containing three unique tandem repeats of 10 hydrophilic amino acids near the C-terminus. The expression of NDRG1 is markedly upregulated in various cells under such conditions as cell differentiation, hypoxia, and exposure to heavy metals. [13] [14] [15] Conversely, its expression is repressed by the Myc family transcription factors and after cellular transformation. 16) Overexpression of NDRG1 in neoplastic cells results in inhibition of cell growth and promotion of epithelial cell differentiation. 17, 18) Mutations in the NDRG1 gene are linked to the hereditary motor and sensory neuropathy. 19) Overall, although accumulating evidence suggests that NDRG1 may be an indicator of cell differentiation and stress, its precise cellular functions and regulatory mechanisms still remain elusive.
In an effort to determine the regulatory functions of NDRG1 in mast cells, we examined the posttranslational modification of NDRG1 in this study. Given that the NDRG1 protein has multiple potential phosphorylation sites 20) and that NDRG1 has recently been shown to be phosphorylated at multiple sites in endothelial cells, 21) we show that NDRG1 exists as a multiphosphorylated protein in mast cells.
MATERIALS AND METHODS

Mast Cell Activation
Rat mastocytoma RBL-2H3 cells (Japanese Cancer Resources Bank) were maintained in RPMI 1640 medium (Nissui Pharmaceutical) containing 10% fetal calf serum, as described previously. 9) Cells (5ϫ10 4 cells/ml) were cultured for 2 d, sensitized with 200 ng/ml IgE anti-dinitrophenyl (DNP) for 2 h, washed twice with culture medium, and then activated for 10 min at 37°C with 10 ng/ml DNPconjugated bovine serum albumin (Sigma) as an antigen (Ag) to assess b-hexosaminidase (b-HEX) release. 8, 9) Preparation of Recombinant NDRG1 Protein cDNAs for the full-length NDRG1 and its truncated form, which lacks the C-terminal three tandem repeats, were prepared as described previously. 9) These cDNA inserts were subcloned into the pET-21c vector (Novagen) at the EcoRI site and transformed into Escherichia coli (BL21(DE3); Invitrogen) and cultured in the presence of 0.4 mM isopropyl-thio-b-Dgalactoside to produce recombinant His 6 We previously demonstrated that the in vitro maturation of mouse immature bone marrow-derived mast cells into a mature connective tissue mast cell-like phenotype is accompanied by a marked induction of N-myc downregulated gene (NDRG) 1, a cytosolic protein with unknown function. Here we show that NDRG1 undergoes phosphorylation in mast cells. Recombinant NDRG1 was phosphorylated by calmodulin kinase-II, protein kinase (PK) A and PKC in vitro. Deletion of the C-terminal tandem repeats of NDRG1 resulted in increased phosphorylation by PKA and PKC, but not by calmodulin kinase-II. Furthermore, NDRG1 was phosphorylated on serine and threonine residues in mast cells, a process that was accelerated transiently following cell activation. Pharmacologic studies using kinase-specific inhibitors demonstrated that this NDRG1 phosphorylation in mast cells depended on calmodulin kinase-II and PKA, but not PKC. Collectively, our results indicate that NDRG1 is a multiphosphorylated protein in mast cells, and that the kinetics of increased NDRG1 phosphorylation parallels signaling events leading to exocytosis. mogeneity according to the manufacturer's instructions and was dialyzed against TBS.
Analysis of Phosphorylation of NDRG1 in Vitro Recombinant His 6 -NDRG1 protein (1 mg) was incubated for 30 min at 30°C with 1000 units of recombinant casein kinase-II (CK-II; Perkin Elmer), 5000 units of protein kinase A (PKA; Perkin Elmer), 0.4 mg/ml protein kinase C (PKC; Molecular Probe), or 800 units of calcium-calmodulin kinase II (CaMK-II; Perkin Elmer) in their respective phosphorylation buffers containing 10 mM MgCl 2 , 40 mM ATP (Sigma) and 10 mCi/ml [g-32 P]ATP (Amersham Bioscience). After brief boiling in sample buffer, aliquots were applied to SDS-PAGE, 9) followed by autoradiography. Analysis of Phosphorylation of NDRG1 in Vivo Subconfluent RBL-2H3 cells (10 7 cells) were incubated with 300 mCi/ml [ 32 P]phosphoric acid (Perkin Elmer) for 4 h in 500 ml of phosphate-free EMEM (Sigma) containing 10% (v/v) dialyzed fetal calf serum and 200 ng/ml anti-TNP IgE. After activation for appropriate periods with DNP-BSA, the cells were lyzed in 20 mM Tris-HCl (pH 7.4) containing 150 mM NaCl, 1% (v/v) NP-40, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM phenylmethanesulfonyl fluoride, 1 mM N-benzoyl-Larginine ethyl ester hydrochloride, 10 mg/ml leupeptin and 10 mg/ml aprotinin on ice. After centrifugation at 15000ϫg for 30 min, the supernatants were incubated with 12 mg of purified anti-NDRG1 antibody 9) and 20 ml of protein GSepharose (Amersham Bioscience) for 2 h at 4°C. After washing six times with the buffer, the immunoprecipitates were applied to SDS-PAGE and subjected to autoradiography (2-h exposure). To assess the effects of protein kinase inhibitors on NDRG1 phosphorylation, 32 P-labeled, IgE-sensitized cells were incubated for 30 min with 10 mM H-89 (PKA inhibitor) (Seikagaku Kogyo), 2 mM GF109203X (PKC inhibitor) (BIOMOL), 10 mM KN-62 (CaMK-II inhibitor) (Sigma), 10 mM 5,6-dichloro-1-b-D-ribofuranosyl benzimidazole (DRB; CK-II inhibitor) (Calbiochem), or vehicle control (dimethyl sulfoxide) in medium and then activated with antigen in the continued presence of each inhibitor.
To perform phosphoamino acid analysis, replicate immunoprecipitates applied to SDS-PAGE were transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA, U.S.A.) and the positions of NDRG1 were precisely cut off. The pieces were incubated with 100 ml of 6 N HCl for 1 h at 110°C. The supernatants were collected, evaporated, and mixed with trace amounts of L-phosphoserine, L-phosphothreonine and L-phosphotyrosine (Sigma). Then the samples were spotted on TLC plates (Merck) and electrophoresed at 1500 V for 25 min at pH 1.9 (2.5% formic acid and 7.8% glacier acetic acid) in the first dimension and at 1300 V for 20 min at pH 3.5 (5% glacier acetic acid and 0.5% pyridine) in the second dimension. After drying, separated amino acids on the plates were visualized with ninhydrin spray at 80°C for 15 min. Incorporation of [ 32 P] into each amino acid was detected autoradiographically.
Other Procedures Protein concentrations were determined using a BCA protein assay kit (Pierce). The procedures for Western blotting were described previously. 8, 9) Data were analyzed using Student's t-test.
RESULTS
Phosphorylation of NDRG1
in Vitro NDRG1 has multiple potential phosphorylation sites, including those for PKA, PKC, CaMK-II, and CK-II (Fig. 1A) . To assess whether NDRG1 undergoes phosphorylation by these protein kinases, we conducted an in vitro kinase assay. When the purified recombinant NDRG1 protein was incubated with PKA, PKC (a mixture of a, b, and g isoforms), and CaMK-II in the presence of [g-32 P]ATP and then subjected to SDS-PAGE followed by autoradiography, there was a marked incorporation of [ 32 P] into the NDRG1 protein (Fig. 1B) . Because three tandem hydrophilic repeats located in the C-terminal portion of NDRG1 are postulated to be crucial for its function, 9) we examined whether the phosphorylation states were altered in an NDRG1 mutant that lacked the tandem repeats. As shown in Fig. 1C , phosphorylation of NDRG1 by PKA or PKC was markedly increased when the C-terminal tandem repeats were deleted, whereas that by CaMK-II was nearly equal between the full-length and truncated forms. Neither full-length nor truncated NDRG1 was phosphorylated by CK-II (Figs. 1B, C) .
Phosphorylation of NDRG1 in Mast Cells
We next assessed whether phosphorylation of NDRG1 occurs in mast cells. To this end, NDRG1 was immunoprecipitated with anti-NDRG1 antibody from the lysates of 32 P-prelabeled RBL-2H3 cells. As shown in Fig. 2 , there was a significant (Fig. 2) . Phosphoamino acid analysis revealed that phosphorylation of NDRG1 in these cells occurred on serine and threonine, but not tyrosine, residues, which was increased significantly over 1 to 5 min after cell activation and declined to the basal level by 10 min (Fig. 3) .
Pretreatment of 32 P-prelabeled RBL-2H3 cells with a specific inhibitor for PKA (H-89) or CaMK-II (KN-82) resulted in a marked reduction of NDRG1 phosphorylation in RBL-2H3 cells (Fig. 4A) . These inhibitors also suppressed IgE/Ag-stimulated exocytosis to the basal level (Fig. 4B) . The PKCa inhibitor GF109203X markedly suppressed IgE/Ag-stimulated exocytosis (Fig. 4B) , while almost no inhibition of NDRG1 phosphorylation by this inhibitor was observed (Fig. 4A) , indicating that the PKC inhibitor blocked post-FceRI signaling independently of NDRG1 phosphorylation. Neither NDRG1 phosphorylation (Fig. 4A ) nor exocytosis (Fig. 4B) was suppressed by the CK-II inhibitor DRB.
DISCUSSION
NDRG1 is a member of the NDRG family that belongs to the a/b hydrolase superfamily, but does not present a hydrolytic catalytic site. 20) Diverse pathologic and physiologic conditions, such as cellular differentiation, hypoxia, and neoplasia, modulate NDRG1 expression, [13] [14] [15] [16] [17] [18] yet its precise cellular functions remain unclear. We have recently found that NDRG1 is markedly upregulated in BMMCs during in vitro maturation into CTMC-like cells and that NDRG1 overexpression renders mast cells hypersensitive to exocytotic stimuli. 9) In an effort to determine the regulatory functions of NDRG1, we here found a novel aspect of NDRG1 in that it is phosphorylated on serine and threonine residues in mast cells, possibly by PKA and CaMK-II.
We found that NDRG1 undergoes phosphorylation in mast cells, predominantly on serine and threonine residues. This phosphorylation was already evident in unstimulated cells and was increased transiently after IgE/Ag activation. The results of in vitro kinase assay and studies using various kinase inhibitors suggest that the kinases capable of phosphorylating NDRG1 in mast cells are PKA and CaMK-II. Although NDRG1 is also phosphorylated by classic PKCs as efficiently as PKA and CaMK-II in vitro, minimal reduction of NDRG1 phosphorylation by a PKC inhibitor in mast cells suggests that the classic PKCs may not represent the major kinase responsible for NDRG1 phosphorylation, at least in mast cells.
Although the reduction of NDRG1 phosphorylation by PKA and CaMK-II inhibitors was accompanied by a marked reduction of mast cell degranulation, it is at present unclear whether this phosphorylation event is directly linked to the degranulation-enhancing capacity of NDRG1 since the pos- sibility that the inhibitors of PKA and CaMK-II blocked upstream signaling steps leading to exocytosis cannot be ruled out. In general, the role of CaMK-II in exocytosis has been documented in neuronal synapses. CaMK-II is localized on the synaptic vesicular membranes and is capable of phosphorylating several proteins of the SNARE (for soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor) system. 22, 23) In response to an increase in intracellular Ca 2ϩ level, activated CaMK-II phosphorylates the synaptic vesicle protein synapsin, which leads to reduced binding of synaptic vesicles to cytoskeletal actin, thereby allowing vesicle-plasma membrane fusion. In contrast, the role of PKA in the regulation of exocytosis has been controversial. PKA accelerates exocytosis in neurons and pancreatic b-cells by sensitizing the Ca 2ϩ response, 24) whereas the functions of SNAREs are suppressed by PKA. 25) Our present data support the former idea that PKA exerts a positive regulatory role in degranulation of RBL-2H3 cells. However, considering the general view that an increase in cAMP, a primary activator of PKA, negatively regulates mast cell activation, [26] [27] [28] the possibility that an unidentified H-89-sensitive kinase distinct from PKA is involved in NDRG1 phosphorylation and exocytosis cannot be ruled out.
In mouse NDRG1 molecule, there are 6, 3 and 10 predicted phosphorylation sites for PKA, PKC, and CaMK-II, respectively (Fig. 1A) . Since phosphorylation of recombinant NDRG1 in vitro by PKA or PKC was markedly enhanced when the C-terminal three tandem repeats were deleted, it appears that this C-terminal region masks the PKA or PKC phosphorylation sites, all of which are located in the NDRG core domain. In contrast, phosphorylation by CaMK-II is not prevented by the C-terminal tandem repeats, although 6 of 10 potential CaMK-II phosphorylation sites are located within the tandem repeats. This also implies that the major CaMK-II phosphorylation sites also reside in the NDRG1 core domain but not in the C-terminal tandem repeats. A previous study demonstrated that NDRG1 is phosphorylated by PKA but not by several other kinases including PKC and CK-II in human endothelial cells, 21) consistent with the results of our present study. In that study, however, the contribution of CaMK-II to NDRG1 phosphorylation remained obscure, since the in vitro kinase assay failed to confirm the CaMK-IImediated phosphorylation of recombinant human NDRG1 in spite of the finding that NDRG1 phosphorylation in endothelial cells was suppressed by the CaMK-II inhibitor R24517. 21 21) Ser 79 of mouse NDRG1 may be a major site phosphorylated by CaMK-II in vitro. Nonetheless, mutating the potential PKA and CaMK-II phosphorylation sites in the NDRG core domain, alone or in combination, would help us to understand the functional linkage between NDRG1 phosphorylation and its regulatory functions including degranulation, cell growth and differentiation, and stress response.
